Journal of Pediatric Neuroradiology 2014; 03(03): 121-126
DOI: 10.3233/PNR-14181
Georg Thieme Verlag KG Stuttgart – New York

Cingulate Apparent Diffusion Coefficient measurements in children with Neurofibromatosis type 1

Nadja Kadom
a   Children’s National Medical Center, Diagnostic Imaging and Radiology, Boston, MA, USA
,
Nabila Hai
a   Children’s National Medical Center, Diagnostic Imaging and Radiology, Boston, MA, USA
,
Rhea Udyavar
a   Children’s National Medical Center, Diagnostic Imaging and Radiology, Boston, MA, USA
,
Amir Noor
a   Children’s National Medical Center, Diagnostic Imaging and Radiology, Boston, MA, USA
,
Roger J. Packer
b   Children’s National Medical Center, Department of Neurology, Boston, MA, USA
,
Gilbert L. Vezina
a   Children’s National Medical Center, Diagnostic Imaging and Radiology, Boston, MA, USA
,
Maria T. Acosta
b   Children’s National Medical Center, Department of Neurology, Boston, MA, USA
› Author Affiliations

Subject Editor:
Further Information

Publication History

24 August 2013

04 April 2014

Publication Date:
29 July 2015 (online)

Abstract

The purpose of this study was to objectively verify and study a bright magnetic resonance imaging T2 signal that was qualitatively observed in the anterior cingulate region in children with neurofibromatosis type 1 (NF1). We performed a retrospective study in children with the cingulate imaging sign with apparent diffusion coefficient (ADC) measurements in the anterior and posterior cingulate region, as well as in a reference region in the vitreous. There were 18 NF1 patients and 18 matched controls age 2–14 yr in whom ADC measurements were performed. We found significantly higher ADC values in NF1 patients in the visibly abnormal anterior cingulate, but also in the normal appearing posterior cingulate regions (p < 0.00001). Major considerations to explain the high ADC values include vasogenic edema and abnormal myelination. Given its location in the cingulate, our observed magnetic resonance imaging sign may bear relevance to cognitive symptoms in NF1 patients and warrants further investigation with correlating studies.